Invention Grant
US07682612B1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
有权
使用嵌合抗CD20抗体治疗与循环肿瘤细胞相关的血液恶性肿瘤
- Patent Title: Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
- Patent Title (中): 使用嵌合抗CD20抗体治疗与循环肿瘤细胞相关的血液恶性肿瘤
-
Application No.: US09436347Application Date: 1999-11-09
-
Publication No.: US07682612B1Publication Date: 2010-03-23
- Inventor: Christine A. White , Antonio J. Grillo-López , John G. Curd , Susan Desmond-Hellmann
- Applicant: Christine A. White , Antonio J. Grillo-López , John G. Curd , Susan Desmond-Hellmann
- Applicant Address: US MA Cambridge US CA South San Francisco
- Assignee: Biogen Idec Inc.,Genentech, Inc.
- Current Assignee: Biogen Idec Inc.,Genentech, Inc.
- Current Assignee Address: US MA Cambridge US CA South San Francisco
- Agency: Sidley Austin LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K51/00
Abstract:
Chronic Lymphocytic Leukemia (CLL) may be treated with antibodies directed against the CD20 antigen.
Information query
